Recent Updates
Recently added Catalysts
VNDA

Vanda Pharmaceuticals Announces Participation at Upcoming 2021 Investor Conferences

Key Takeaway: WASHINGTON, May 12, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Vanda's management will participate at the following investor conferences: Bank of America Securities 2021 Virtual Health Care Conference on Thursday, May 13, 2021 at

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis

Full Press Release Details

WASHINGTON, May 12, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Vanda's management will participate at the following investor conferences:
Bank of America Securities 2021 Virtual Health Care Conference on Thursday, May 13, 2021 at 11:00 AM ET.
Oppenheimer Virtual Rare & Orphan Disease Summit on Friday, May 21, 2021 at 2:05 PM ET.
Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 1:00 PM ET.
The Bank of America, Oppenheimer, and Jefferies conferences may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the links under Recent Events. Investors are advised to go to the conference websites at least 15 minutes early to register, download, and install any necessary software or presentations. Links to the archived conferences will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Chief Corporate Affairs and Communications Officer
Vanda Pharmaceuticals Inc.
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
Last updated: May 12, 2021